BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 30321193)

  • 1. Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review.
    Wortman MSH; Lokkerbol J; van der Wouden JC; Visser B; van der Horst HE; Olde Hartman TC
    PLoS One; 2018; 13(10):e0205278. PubMed ID: 30321193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a cost-effectiveness study.
    van Ravesteijn H; Grutters J; olde Hartman T; Lucassen P; Bor H; van Weel C; van der Wilt GJ; Speckens A
    J Psychosom Res; 2013 Mar; 74(3):197-205. PubMed ID: 23438709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of interventions for treating anxiety disorders: A systematic review.
    Ophuis RH; Lokkerbol J; Heemskerk SC; van Balkom AJ; Hiligsmann M; Evers SM
    J Affect Disord; 2017 Mar; 210():1-13. PubMed ID: 27988373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol.
    Jadhakhan F; Lindner OC; Blakemore A; Guthrie E
    BMJ Open; 2019 Jul; 9(7):e027922. PubMed ID: 31270115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics of medically unexplained symptoms: a systematic review of the literature.
    Konnopka A; Schaefert R; Heinrich S; Kaufmann C; Luppa M; Herzog W; König HH
    Psychother Psychosom; 2012; 81(5):265-75. PubMed ID: 22832397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which interventions are cost-effective for the management of whiplash-associated and neck pain-associated disorders? A systematic review of the health economic literature by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.
    van der Velde G; Yu H; Paulden M; Côté P; Varatharajan S; Shearer HM; Wong JJ; Randhawa K; Southerst D; Mior S; Sutton D; Jacobs C; Taylor-Vaisey A
    Spine J; 2016 Dec; 16(12):1582-1597. PubMed ID: 26631759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility of a specific collaborative group intervention for patients with functional somatic syndromes.
    Konnopka A; König HH; Kaufmann C; Egger N; Wild B; Szecsenyi J; Herzog W; Schellberg D; Schaefert R
    J Psychosom Res; 2016 Nov; 90():43-50. PubMed ID: 27772558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness Analysis of a Stepped, Collaborative and Coordinated Health Care Network for Patients with Somatoform Disorders (Sofu-Net).
    Grochtdreis T; Brettschneider C; Shedden-Mora M; Piontek K; König HH; Löwe B
    J Ment Health Policy Econ; 2018 Jun; 21(2):59-69. PubMed ID: 29961045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of medically unexplained symptoms in adults who are high users of healthcare services and magnitude of associated costs: a systematic review.
    Jadhakhan F; Romeu D; Lindner O; Blakemore A; Guthrie E
    BMJ Open; 2022 Oct; 12(10):e059971. PubMed ID: 36198445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of health economic studies in cranial neurosurgery.
    Ryu WHA; Yang MMH; Muram S; Jacobs WB; Casha S; Riva-Cambrin J
    Neurosurg Focus; 2018 May; 44(5):E2. PubMed ID: 29712519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses.
    Hettiarachchi RM; Kularatna S; Downes MJ; Byrnes J; Kroon J; Lalloo R; Johnson NW; Scuffham PA
    Community Dent Oral Epidemiol; 2018 Apr; 46(2):118-124. PubMed ID: 28925508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review.
    Pinto D; Robertson MC; Hansen P; Abbott JH
    Value Health; 2012 Jan; 15(1):1-12. PubMed ID: 22264966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medically Unexplained Symptoms (MUS): Faults and Implications.
    Tack M
    Int J Environ Res Public Health; 2019 Apr; 16(7):. PubMed ID: 30965593
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.